274 related articles for article (PubMed ID: 23288234)
1. Neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report.
Yamashita T; Fujii Y; Misawa F
J Clin Psychopharmacol; 2013 Feb; 33(1):127-9. PubMed ID: 23288234
[No Abstract] [Full Text] [Related]
2. Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
Ghio L; Fornaro G; Rossi P
J Clin Psychopharmacol; 2009 Aug; 29(4):391-2. PubMed ID: 19593182
[No Abstract] [Full Text] [Related]
3. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
Mall GD; Hake L; Benjamin AB; Adityanjee A
J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
[No Abstract] [Full Text] [Related]
4. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
Mané A; Baeza I; Morer A; Lázaro ML; Bernardo M
J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
[No Abstract] [Full Text] [Related]
5. Neuroleptic Malignant Syndrome After Early Administration of Risperidone Long-Acting Injection.
Mitchell BG; McMahon BC; Mitchell CW
Prim Care Companion CNS Disord; 2017 Nov; 19(6):. PubMed ID: 29195036
[No Abstract] [Full Text] [Related]
6. Atypical neuroleptic malignant syndrome associated with iloperidone administration.
Guanci N; Aggarwal R; Schleifer S
Psychosomatics; 2012; 53(6):603-5. PubMed ID: 23157999
[No Abstract] [Full Text] [Related]
7. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
8. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
Villanueva Lamas J; García García J; Alda Diez JA; Tous Andreu N
An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
[No Abstract] [Full Text] [Related]
9. Neuroleptic malignant syndrome associated with use of risperidone, ritonavir, and indinavir: a case report.
Lee SI; Klesmer J; Hirsch BE
Psychosomatics; 2000; 41(5):453-4. PubMed ID: 11015640
[No Abstract] [Full Text] [Related]
10. Neuroleptic malignant syndrome and risperidone: a case report.
Bonwick RJ; Hopwood MJ; Morris PL
Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
12. [Neuroleptic malignant syndrome in users of risperidone].
Bonte-Mineur F; Geerlings CJ; Rietveld AP
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
[No Abstract] [Full Text] [Related]
13. [Neuroleptic malignant syndrome in users of risperidone].
Kroon JG
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594
[No Abstract] [Full Text] [Related]
14. The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection.
Peng PW; Huang MC; Tsai CJ; Pan CH; Chen CC; Chiu CC
J Clin Psychopharmacol; 2008 Dec; 28(6):726-7; author reply 727-8. PubMed ID: 19011459
[No Abstract] [Full Text] [Related]
15. [Neuroleptic malignant syndrome in users of risperidone].
van Bemmel T; Westendorp RG
Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
[No Abstract] [Full Text] [Related]
16. [Neuroleptic malignant syndrome in users of risperidone].
van Waarde JA; Kuiper J; Verwey B
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):156-7; author reply 157. PubMed ID: 15693593
[No Abstract] [Full Text] [Related]
17. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
18. Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report.
Langley-DeGroot M; Joshi Y; Lehman D; Rao S
J Clin Psychopharmacol; 2016 Jun; 36(3):277-9. PubMed ID: 27043124
[No Abstract] [Full Text] [Related]
19. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
[No Abstract] [Full Text] [Related]
20. Comments on the report of neuroleptic malignant syndrome induced by ziprasidone.
Margetic B; Aukst-Margetic B
World J Biol Psychiatry; 2007; 8(2):131-2; author reply 133-4. PubMed ID: 17455107
[No Abstract] [Full Text] [Related]
[Next] [New Search]
